Brief: Abivax Posts H1 Operating Loss Of EUR 37.3 Million

Abivax SA

21/09/2023 17:45

Sept 21 (Reuters) - Abivax SA  ABVX.PA :
    * ABIVAX PRESENTS FIRST-HALF 2023 FINANCIAL RESULTS
    * OPERATING LOSS OF EUR -37.3M AS OF JUNE 30, 2023
    * CASH AT END OF JUNE 2023 WAS EUR +114.4M, COMPARED TO EUR
+27.0M
AT END OF 2022.
    * NEW STRATEGIC PRE-CLINICAL AND CLINICAL INITIATIVES, AS
WELL AS
EXPANSION OF ABIVAX'S CLINICAL, MEDICAL AND COMMERCIAL
CAPABILITIES, WILL REQUIRE ADDITIONAL CAPITAL.
    * NET LOSS AMOUNTED TO EUR -52.0M AS OF JUNE 30, 2023, AN
INCREASE
OF EUR -30.8M COMPARED TO EUR

Source text for Eikon:  ID:nEQ4N7vlma 
Further company coverage:  ABVX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))